PARK MEDI WORLD IPO

PARK MEDI WORLD IPO

Dhan Kirti is pleased to present an in-depth analysis of the upcoming Initial Public Offering (IPO) by Park Medi World Limited, a prominent healthcare provider set to list on the Indian stock exchanges. This IPO presents an opportunity for investors to participate in the growth story of a significant player in North India’s healthcare sector. Park Medi World has established itself as a multi-super specialty hospital chain with a robust operational model and ambitious expansion plans. Delving into the details of their offering, this article aims to provide a comprehensive overview of the company, its financial aspirations, and the investment considerations for potential subscribers.

Key IPO Details at a Glance

The Park Medi World IPO is structured to raise a substantial amount, reflecting the company’s strategic vision for expansion and debt reduction. The price band offers investors a clear range for subscription, while the lot size defines the minimum investment required to participate in this offering.

Important Dates for Investors

• Opening Date: 10 Dec 2025
• Closing Date: 12 Dec 2025
• UPI Payment Deadline: 12 Dec 2025 (5 PM)
• Allotment Announcement: 15 Dec 2025
• Refund Processing: 16 Dec 2025
• Demat Credit: 16 Dec 2025
• Stock Market Listing: 17 Dec 2025
• Mandate Validity End: 27 Dec 2025
• Anchor Investor Lock-in Release (50%): 14 Jan 2026
• Anchor Investor Lock-in Release (Remaining): 15 Mar 2026

*Dates may be revised as per official updates. Investors are advised to refer to the official prospectus for any final changes.

About the Issuer: Park Medi World

Founded in 2000, Park Medi World has grown from a single clinic in Delhi into a major regional healthcare network. The company operates in the multi-super specialty hospital sector, specializing in a comprehensive range of medical services. As of March 31, 2025, it stands as the second-largest private hospital chain in North India with an impressive capacity of 3,000 beds, and holds the distinction of being the largest in Haryana with 1,600 beds. The company manages 14 NABH-accredited multi-super specialty hospitals under the ‘Park’ brand, eight of which are also NABL-accredited, underscoring its commitment to quality healthcare standards.

Park Medi World caters to patients across Haryana, Delhi, Punjab, and Rajasthan, offering a diverse array of over 30 specialties including neurology, gastroenterology, orthopedics, oncology, and critical care. This extensive service portfolio is supported by a dedicated team of 1,014 doctors and 2,142 nurses. The company’s strategic cluster-based growth model is a key driver for operational efficiency, strong patient delivery outcomes, and achieving economies of scale within its target markets. Led by Dr. Ajit Gupta, the chain has strategically expanded through organic growth and acquisitions. Its bed capacity has seen significant growth, from 2,550 in FY23 to 3,250 in FY25, with further expansion plans targeting 4,900 beds by March 2028 through ongoing projects in Ambala, Panchkula, Rohtak, Gorakhpur, and Kanpur. With advanced infrastructure including modern ICUs, operating theatres, robotic surgery programs (iMARS), and specialized trauma and cancer care facilities, Park Medi World is well-positioned to deliver high-quality and affordable healthcare while pursuing its next phase of growth across North India.

Understanding the IPO Structure and Capital Raise

The total issue size of ₹920 crore for Park Medi World’s IPO is bifurcated into two main components. A fresh issue of ₹770 crore signifies new capital being raised by the company, the proceeds of which will directly contribute to its growth initiatives and financial objectives. This fresh capital is crucial for funding the company’s expansion plans, repaying borrowings, and enhancing its operational capabilities. The remaining ₹150 crore is an Offer for Sale (OFS), where existing shareholders will divest a portion of their holdings. The proceeds from the OFS will go to these selling shareholders, rather than to the company itself. This structure allows the company to raise capital for its future while also providing liquidity to its early investors.

Strategic Utilization of Funds

The capital raised through the fresh issue component of the IPO is strategically earmarked to bolster Park Medi World’s financial health and fuel its growth. A significant portion, nearly half (49.35%), is allocated towards the repayment or prepayment of existing borrowings, which is expected to strengthen the company’s balance sheet by reducing its debt burden and potentially lowering finance costs. Furthermore, a combined 11.43% (7.86% + 3.57%) is designated for capital expenditure, focusing on the development and expansion of new and existing hospitals, specifically Park Medicity and Blue Heavens, along with the procurement of essential medical equipment for these facilities and Ratangiri. This investment in infrastructure and technology is vital for enhancing patient care and increasing operational capacity. The remaining 39.22% is allocated for general corporate purposes, providing the company with financial flexibility for various strategic initiatives, operational needs, and potential inorganic growth opportunities.

Distinctive Advantages of Park Medi World

• Multi-Specialty Hospital Network with Strong Regional Presence: The company boasts a well-established network of multi-specialty hospitals, particularly noted for its significant presence in the National Capital Region (NCR) and across North India. This broad geographical footprint and comprehensive service offering attract a wide patient base.
• Experienced Medical Professionals and Seasoned Promoter Team: Park Medi World benefits from a strong foundation built on the expertise of its medical professionals and the visionary leadership of its promoter team. Their experience is crucial in maintaining high standards of care and steering strategic growth.
• High-End Medical Infrastructure with Advanced Facilities: The company has invested in advanced diagnostic and treatment facilities, including state-of-the-art ICUs, operating theatres, and robotic surgery programs. This high-end infrastructure enables superior patient outcomes and strengthens its competitive position.
• Strong Focus on Affordable Care Driving Patient Footfall: By emphasizing affordable care, Park Medi World effectively caters to a larger segment of the population, ensuring high patient footfall across its various departments. This approach combines quality with accessibility, a critical factor in the Indian healthcare landscape.
• Strategic Expansion and Capacity Enhancement: With ongoing expansion projects and plans for capacity enhancement at key hospitals, the company is proactively preparing for future growth. This commitment to increasing its bed count and service offerings underscores its forward-looking strategy.

Navigating Investment Risks

• High Dependence on Key Doctors and Specialists: The company’s ability to attract and retain key doctors and specialists is vital for patient inflow and revenue generation. The departure of these professionals could significantly impact operations and reputation.
• Regulatory Risks in the Healthcare Sector: The healthcare industry is subject to stringent regulatory compliance requirements. Any changes in regulations or failure to comply could lead to penalties, operational disruptions, or increased costs.
• Significant Working Capital and Capex Needs: Running a hospital chain requires substantial working capital and ongoing capital expenditure for maintenance, upgrades, and expansion. These needs could strain cash flows if not managed effectively.
• Intense Competition: Park Medi World operates in a highly competitive market, facing strong competition from both established national hospital chains and various local players in its operating regions. This competition could affect pricing power and market share.
• Clinical Negligence or Service-Quality Issues: Any instance of clinical negligence, lapses in patient care, or perceived service-quality issues could severely damage the company’s reputation, erode public trust, and negatively impact patient volumes and revenue.

Investor Demand Tracker

Subscription statistics for the Park Medi World IPO will be dynamically updated based on the latest available information during the bidding period. Investors are encouraged to monitor these figures closely to gauge overall market interest across different investor categories.

*This data will be updated as subscription progresses. Exchange data is generally considered the most reliable source for these figures.

Participating in the Park Medi World IPO

Investors interested in subscribing to the Park Medi World IPO can participate via the official Dhan Kirti IPO platform. Ensure you complete your application before the subscription window closes on 12th December 2025.